BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25892506)

  • 21. Estrogen receptor α and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models.
    Gingerich S; Kim GL; Chalmers JA; Koletar MM; Wang X; Wang Y; Belsham DD
    Neuroscience; 2010 Sep; 170(1):54-66. PubMed ID: 20619320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor α and G-protein coupled estrogen receptor 1 are localized to GABAergic neurons in the dorsal striatum.
    Almey A; Milner TA; Brake WG
    Neurosci Lett; 2016 May; 622():118-23. PubMed ID: 27080432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 17β-Estradiol upregulates ecto-5'-nucleotidase (CD73) in hippocampal synaptosomes of female rats through action mediated by estrogen receptor-α and -β.
    Mitrović N; Zarić M; Drakulić D; Martinović J; Stanojlović M; Sévigny J; Horvat A; Nedeljković N; Grković I
    Neuroscience; 2016 Jun; 324():286-96. PubMed ID: 26987957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.
    Morissette M; Le Saux M; D'Astous M; Jourdain S; Al Sweidi S; Morin N; Estrada-Camarena E; Mendez P; Garcia-Segura LM; Di Paolo T
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):327-38. PubMed ID: 17936613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
    Callier S; Morissette M; Grandbois M; Pélaprat D; Di Paolo T
    Synapse; 2001 Aug; 41(2):131-8. PubMed ID: 11400179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
    Schaufelberger SA; Rosselli M; Barchiesi F; Gillespie DG; Jackson EK; Dubey RK
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E313-22. PubMed ID: 26732685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERalpha in primary cultures of mouse mesencephalon.
    Bains M; Cousins JC; Roberts JL
    Exp Neurol; 2007 Apr; 204(2):767-76. PubMed ID: 17320868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The G protein-coupled oestrogen receptor, GPER1, mediates direct anti-inflammatory effects of oestrogens in human cholinergic neurones from the nucleus basalis of Meynert.
    Sarchielli E; Guarnieri G; Idrizaj E; Squecco R; Mello T; Comeglio P; Gallina P; Maggi M; Vannelli GB; Morelli A
    J Neuroendocrinol; 2020 Mar; 32(3):e12837. PubMed ID: 32077170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of Signalling by the Endogenous GPER1 (GPR30) Receptor in an Embryonic Mouse Hippocampal Cell Line (mHippoE-18).
    Evans NJ; Bayliss AL; Reale V; Evans PD
    PLoS One; 2016; 11(3):e0152138. PubMed ID: 26998610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?
    Soldati R; Wargon V; Cerliani JP; Giulianelli S; Vanzulli SI; Gorostiaga MA; Bolado J; do Campo P; Molinolo A; Vollmer G; Lanari C
    Breast Cancer Res Treat; 2010 Oct; 123(3):709-24. PubMed ID: 20012353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GPER1 mediates estrogen-induced neuroprotection against oxygen-glucose deprivation in the primary hippocampal neurons.
    Zhao TZ; Shi F; Hu J; He SM; Ding Q; Ma LT
    Neuroscience; 2016 Jul; 328():117-26. PubMed ID: 27113328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.
    Bourque M; Dluzen DE; Di Paolo T
    Front Neuroendocrinol; 2012 Apr; 33(2):169-78. PubMed ID: 22387674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol.
    Jover-Mengual T; Castelló-Ruiz M; Burguete MC; Jorques M; López-Morales MA; Aliena-Valero A; Jurado-Rodríguez A; Pérez S; Centeno JM; Miranda FJ; Alborch E; Torregrosa G; Salom JB
    J Steroid Biochem Mol Biol; 2017 Jul; 171():296-304. PubMed ID: 28479229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S; Morissette M; Morin N; Di Paolo T
    J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estradiol upregulates voltage-gated sodium channel 1.7 in trigeminal ganglion contributing to hyperalgesia of inflamed TMJ.
    Bi RY; Meng Z; Zhang P; Wang XD; Ding Y; Gan YH
    PLoS One; 2017; 12(6):e0178589. PubMed ID: 28582470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line.
    Sirianni R; Chimento A; Ruggiero C; De Luca A; Lappano R; Andò S; Maggiolini M; Pezzi V
    Endocrinology; 2008 Oct; 149(10):5043-51. PubMed ID: 18566133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons.
    Cordey M; Pike CJ
    Brain Res; 2005 May; 1045(1-2):217-23. PubMed ID: 15910780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G protein-coupled estrogen receptor is involved in the neuroprotective effect of IGF-1 against MPTP/MPP
    Yuan LJ; Wang XW; Wang HT; Zhang M; Sun JW; Chen WF
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105384. PubMed ID: 31175966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 17β-estradiol rapidly attenuates P2X3 receptor-mediated peripheral pain signal transduction via ERα and GPR30.
    Lu Y; Jiang Q; Yu L; Lu ZY; Meng SP; Su D; Burnstock G; Ma B
    Endocrinology; 2013 Jul; 154(7):2421-33. PubMed ID: 23610132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
    Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.